The Framingham Heart Study

Background Sinking prebeta lipoprotein is a putative marker for elevated levels of lipoprotein (a). Although prospective data suggest that increased plasma lipoprotein (a) is an independent risk factor for coronary heart disease in men, no prospective studies are available in women. Methods and Results From 1968 through 1975, sinking prebeta lipoprotein was determined by paper electrophoresis in 3103 women Framingham Heart Study participants who were free of prevalent cardiovascular disease. A sinking prebeta lipoprotein band was detectable in 434 of the women (14%) studied. The median follow-up interval was approximately 12 years. Incident cardiovascular disease was associated with band presence using a proportional hazards model that included age, smoking, body mass index, systolic blood pressure, glucose intolerance, lowand high-density lipoprotein cholesterol, and ECG left ventricular hypertrophy. Multivariable adjusted relative risk estimates (with 95% confidence intervals) for outcomes in the band present versus absent groups were as follows: myocardial infarction (82 events), 2.37

[1]  Darrell M. Wilson,et al.  Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. , 2009, The American journal of clinical nutrition.

[2]  J. Norris,et al.  Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. , 2009, The Journal of clinical endocrinology and metabolism.

[3]  R. Vasan,et al.  Abdominal Subcutaneous Adipose Tissue: A Protective Fat Depot? , 2009, Diabetes Care.

[4]  M. Holick,et al.  Vitamin D status: measurement, interpretation, and clinical application. , 2009, Annals of epidemiology.

[5]  Stefan Pilz,et al.  Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.

[6]  E. Rimm,et al.  25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. , 2008, Archives of internal medicine.

[7]  R. Jorde,et al.  Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index , 2008, European journal of nutrition.

[8]  M. Horowitz,et al.  Vitamin D, glucose, insulin, and insulin sensitivity. , 2008, Nutrition.

[9]  D. Mauricio,et al.  Role of vitamin D in the pathogenesis of type 2 diabetes mellitus , 2008, Diabetes, obesity & metabolism.

[10]  J. Kichler,et al.  Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. , 2008, Metabolism: clinical and experimental.

[11]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[12]  P. Tseke,et al.  Vitamin D, the renin-angiotensin system, and insulin resistance , 2008, International Urology and Nephrology.

[13]  J. Murabito,et al.  Visceral and Subcutaneous Adipose Tissue Volumes Are Cross-Sectionally Related to Markers of Inflammation and Oxidative Stress: The Framingham Heart Study , 2007, Circulation.

[14]  Udo Hoffmann,et al.  Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study , 2007, Circulation.

[15]  A. Mitrakou,et al.  The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic Adults , 2007, Diabetes Care.

[16]  Keith C. Norris,et al.  Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. , 2007, Archives of internal medicine.

[17]  Qiong Yang,et al.  The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. , 2007, American journal of epidemiology.

[18]  Zhenqi Liu.  The renin-angiotensin system and insulin resistance , 2007, Current diabetes reports.

[19]  C. Fox,et al.  Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography , 2007, International Journal of Obesity.

[20]  M. Chonchol,et al.  25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. , 2007, Kidney international.

[21]  R. Wood,et al.  Vitamin D status and the metabolic syndrome. , 2006, Nutrition reviews.

[22]  J. Manson,et al.  Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. , 2005, Diabetes care.

[23]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[24]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[25]  M. Visser,et al.  Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. , 2005, The Journal of clinical endocrinology and metabolism.

[26]  E. Ford,et al.  Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. , 2005, Diabetes care.

[27]  A. Looker.  Body fat and vitamin D status in black versus white women. , 2005, The Journal of clinical endocrinology and metabolism.

[28]  B. Boucher,et al.  Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. , 2004, The American journal of clinical nutrition.

[29]  M. Saad,et al.  Hypovitaminosis D is associated with insulin resistance and β cell dysfunction , 2004 .

[30]  J. Yanovski,et al.  The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. , 2004, The Journal of clinical endocrinology and metabolism.

[31]  C. Thomas,et al.  PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. , 2003, Medical hypotheses.

[32]  T. Spector,et al.  Moderate alcohol consumption, estrogen replacement therapy, and physical activity are associated with increased insulin sensitivity: is abdominal adiposity the mediator? , 2003, Diabetes care.

[33]  E. Wolf,et al.  Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  M. Holick,et al.  Decreased bioavailability of vitamin D in obesity. , 2000, The American journal of clinical nutrition.

[35]  M. Holick,et al.  Environmental factors that influence the cutaneous production of vitamin D 13 , 1995 .

[36]  M. Riddle,et al.  Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. , 1994, The American journal of clinical nutrition.

[37]  G A Colditz,et al.  Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. , 1992, American journal of epidemiology.

[38]  L. Lind,et al.  Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. , 1989, Diabetes research.

[39]  A. Norman,et al.  Rapid normalization/stimulation by 1,25-dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat. , 1987, Endocrinology.

[40]  J N Morris,et al.  Assessment methods for physical activity and physical fitness in population studies: report of a NHLBI workshop. , 1986, American heart journal.

[41]  C. Paterson,et al.  Vitamin D nutrition in relation to season and occupation. , 1981, The American journal of clinical nutrition.

[42]  G. Grodsky,et al.  Vitamin D deficiency inhibits pancreatic secretion of insulin. , 1980, Science.

[43]  W. Kannel,et al.  An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.

[44]  C. Rich,et al.  Deposition in and release of vitamin D3 from body fat: evidence for a storage site in the rat. , 1971, The Journal of clinical investigation.

[45]  T. Dawber,et al.  Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.

[46]  R. Vasan,et al.  Subcutaneous Abdominal Adipose Tissue: a Protective Fat Depot? , 2009 .

[47]  Caroline,et al.  Patterns of Abdominal Fat Distribution: The Framingham Heart Study , 2008 .

[48]  R. Wood.  Vitamin D and adipogenesis: new molecular insights. , 2008, Nutrition reviews.

[49]  J. Aloia,et al.  Body fat content and 25-hydroxyvitamin D levels in healthy women. , 2003, The Journal of clinical endocrinology and metabolism.

[50]  E. Bonora,et al.  Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. , 2000, Diabetes care.